Conti, Janet
McCormack, Madalyn
Heruc, Gabriella
Prnjak, Katarina
Barns, Rebecca
McLean, Siân A.
Hay, Phillipa https://orcid.org/0000-0003-0296-6856
Funding for this research was provided by:
Australia and New Zealand Academy for Eating Disorders
Article History
Received: 4 November 2024
Accepted: 2 June 2025
First Online: 16 July 2025
Declarations
:
: This research was approved by the HREC at the Western Sydney University (H15252).
: All provided consent to participation. In accordance with this all transcript data has been de-identified through pseudonyms and participants were invited to remove any further identifying data and to review the analysis for consistency and resonance with their experiences.
: The authors JC and MM declare that they have no competing interests. Author PH has received sessional fees from the Therapeutic Guidelines publication and the Health Education and Training Institute (HETI, NSW), and royalties/honoraria from Hogrefe and Huber, McGraw Hill Education, Blackwell Scientific Publications, BioMed Central, and PLOS Medicine. She has been a consultant to Takeda Pharmaceuticals and is on the Scientific Advisory Board of Tryptamine Therapeutics. Author GH was employed by ANZAED as the Credentialing Director for the Credential program with funding support from the Australian Government Department of Health and Aged Care. Author SM is the Past President of ANZAED and is the Chair of the ANZAED Credentialing Governing Council.